Loading...
Header Logo
Keywords
Last Name
Institution

BRIAN J MILES

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Urology
DivisionUrology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Haque W, Aghazadeh M, Miles BJ, Satkunasivam R, Butler EB, Teh BS. Clinical benefit of treatment for metastatic renal cell cancer at high volume facilities. Ann Transl Med. 2018 Dec; 6(Suppl 2):S90. PMID: 30740411.
      View in: PubMed
    2. Satkunasivam R, Tallman CT, Taylor JM, Miles BJ, Klaassen Z, Wallis CJD. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes. Eur Urol Oncol. 2019 Jul; 2(4):443-447. PMID: 31277781.
      View in: PubMed
    3. Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, Kadmon D, Miles B, Smith C, Ittmann M, Rowley D, Sreekumar A, Creighton CJ, Ayala G. Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139. PMID: 29131367.
      View in: PubMed
    4. De Vivar AD, Sayeeduddin M, Rowley D, Cubilla A, Miles B, Kadmon D, Ayala G. Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3). Hum Pathol. 2017 05; 63:202-211. PMID: 28315427.
      View in: PubMed
    5. Farach A, Ding Y, Lee M, Creighton C, Delk NA, Ittmann M, Miles B, Rowley D, Farach-Carson MC, Ayala GE. Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate. 2016 10; 76(14):1312-25. PMID: 27403603.
      View in: PubMed
    6. Aghazadeh MA, Mercado MA, Pan MM, Miles BJ, Goh AC. Performance of robotic simulated skills tasks is positively associated with clinical robotic surgical performance. BJU Int. 2016 Sep; 118(3):475-81. PMID: 27104883.
      View in: PubMed
    7. Chan R, Munoz A, Wenker EP, Whipple M, Miles B, Boone TB. Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men. Urology. 2016 05; 91:150-3. PMID: 26829718.
      View in: PubMed
    8. Kim MJ, Divatia MK, Lee JH, Shen S, Miles BJ, Hwang JH, Ayala AG, Ro JY. Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas? Int J Clin Exp Pathol. 2015; 8(4):3469-76. PMID: 26097531.
      View in: PubMed
    9. Goh AC, Aghazadeh MA, Krasnow RE, Pastuszak AW, Stewart JN, Miles BJ. Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description. J Endourol. 2015 Nov; 29(11):1217-20. PMID: 25556514.
      View in: PubMed
    10. Okoye E, Choi EK, Divatia M, Miles BJ, Ayala AG, Ro JY. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. Int J Clin Exp Pathol. 2014; 7(12):9061-6. PMID: 25674288.
      View in: PubMed
    11. Bianco FJ, Albala DM, Belkoff LH, Miles BJ, Peabody JO, He W, Bradt JS, Haas GP, Ahlering TE. A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy. J Urol. 2015 Apr; 193(4):1305-10. PMID: 25281778.
      View in: PubMed
    12. Miyai K, Kristiansen A, Egevad L, Pina-Oviedo S, Divatia MK, Shen SS, Miles BJ, Ayala AG, Park YW, Ro JY. Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance. Hum Pathol. 2014 Sep; 45(9):1805-12. PMID: 24993314.
      View in: PubMed
    13. Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions. Int J Clin Exp Pathol. 2014; 7(5):2518-26. PMID: 24966964.
      View in: PubMed
    14. Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion. Hum Pathol. 2014 Aug; 45(8):1572-81. PMID: 24842280.
      View in: PubMed
    15. Ding Y, He D, Florentin D, Frolov A, Hilsenbeck S, Ittmann M, Kadmon D, Miles B, Rowley D, Ayala G. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6101-11. PMID: 24097862.
      View in: PubMed
    16. Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44. PMID: 23395803.
      View in: PubMed
    17. Stamatakis L, Cheng PJ, Ho PL, Thrall MJ, Mayer WA, Miles BJ, Link RE. A 60-year-old woman with an incidentally discovered right renal mass. Urology. 2012 Dec; 80(6):1183-6. PMID: 23206761.
      View in: PubMed
    18. Goh AC, Goldfarb DW, Sander JC, Miles BJ, Dunkin BJ. Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills. J Urol. 2012 Jan; 187(1):247-52. PMID: 22099993.
      View in: PubMed
    19. Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Clin Cancer Res. 2011 Nov 15; 17(22):7174-82. PMID: 21933889.
      View in: PubMed
    20. Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway C, Babaian R, Pisters L, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med. 2011 Apr; 73(3):218-25. PMID: 21257977.
      View in: PubMed
    21. Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR. Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol. 2011 Jan; 178(1):79-87. PMID: 21224046.
      View in: PubMed
    22. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65. PMID: 20819141.
      View in: PubMed
    23. Khavari R, Stamatakis L, Miles B. Robot-assisted laparoscopic prostatectomy performed in a patient with severe thrombocytopenia due to primary myelofibrosis. Can Urol Assoc J. 2009 Aug; 3(4):E23-E24. PMID: 19672431.
      View in: PubMed
    24. Mistry S, Mayer W, Khavari R, Ayala G, Miles B. Can Urol Assoc J. 2009 Jun; 3(3):205-210. PMID: 19543463.
      View in: PubMed
    25. Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603. PMID: 19047084.
      View in: PubMed
    26. Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D. Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8. PMID: 19010869.
      View in: PubMed
    27. Volk RJ, Jibaja-Weiss ML, Hawley ST, Kneuper S, Spann SJ, Miles BJ, Hyman DJ. Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy. Patient Educ Couns. 2008 Dec; 73(3):482-9. PMID: 18760888.
      View in: PubMed
    28. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE. Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2008 Feb; 39(2):282-91. PMID: 18206496.
      View in: PubMed
    29. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2007 Nov; 38(11):1611-20. PMID: 17868773.
      View in: PubMed
    30. Yang G, Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, Thompson TC. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol. 2007 Nov; 38(11):1688-95. PMID: 17707459.
      View in: PubMed
    31. Teh BS, Bastasch MD, Mai WY, Kadmon D, Miles BJ, Butler EB. Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy. Am J Clin Oncol. 2007 Aug; 30(4):395-400. PMID: 17762440.
      View in: PubMed
    32. Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15; 12(16):4872-5. PMID: 16914574.
      View in: PubMed
    33. Miles BJ, Khera M. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3. PMID: 16763638.
      View in: PubMed
    34. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. PMID: 16609032.
      View in: PubMed
    35. Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D. Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer. Mol Ther. 2006 Apr; 13(4):716-28. PMID: 16480930.
      View in: PubMed
    36. Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol Cancer Res Treat. 2006 Feb; 5(1):23-36. PMID: 16417399.
      View in: PubMed
    37. Subramanian VS, Coburn M, Miles BJ. Carcinosarcoma of the prostate with multiple metastases: case report and review of the literature. Urol Oncol. 2005 May-Jun; 23(3):181-3. PMID: 15907718.
      View in: PubMed
    38. Shariat SF, Naderi AS, Miles B, Slawin KM. Anomalies of the wolffian duct derivatives encountered at radical prostatectomy. Rev Urol. 2005; 7(2):75-80. PMID: 16985813.
      View in: PubMed
    39. Canto EI, Singh H, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol. 2004 Sep; 172(3):900-4. PMID: 15310993.
      View in: PubMed
    40. Satoh T, Teh BS, Timme TL, Mai WY, Gdor Y, Kusaka N, Fujita T, Pramudji CK, Vlachaki MT, Ayala G, Wheeler T, Amato R, Miles BJ, Kadmon D, Butler EB, Thompson TC. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):562-71. PMID: 15145177.
      View in: PubMed
    41. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol. 2004 May; 171(5):1850-4. PMID: 15076292.
      View in: PubMed
    42. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, Kadmon D, Miles BJ, Slawin KM. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology. 2004 May; 63(5):905-10; discussion 910-1. PMID: 15134977.
      View in: PubMed
    43. Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1520-9. PMID: 15050332.
      View in: PubMed
    44. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004 Mar; 171(3):1089-92. PMID: 14767277.
      View in: PubMed
    45. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. J Urol. 2004 Jan; 171(1):204-9. PMID: 14665877.
      View in: PubMed
    46. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003 Sep 01; 56(4):256-62. PMID: 12858353.
      View in: PubMed
    47. Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Therapeutic targets for metastatic prostate cancer. Curr Drug Targets. 2003 Apr; 4(3):251-61. PMID: 12643475.
      View in: PubMed
    48. Simon MA, Miles BJ. Benign fibrous histiocytoma: a rare finding on bone scan staging for prostate adenocarcinoma. Urol Oncol. 2003 Jan-Feb; 21(1):45-7. PMID: 12684127.
      View in: PubMed
    49. Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. The role of caveolin-1 in androgen insensitive prostate cancer. J Urol. 2002 Oct; 168(4 Pt 1):1589-96. PMID: 12352463.
      View in: PubMed
    50. Bastasch MD, Teh BS, Mai WY, Carpenter LS, Lu HH, Chiu JK, Woo SY, Grant WH, Miles BJ, Kadmon D, Butler EB. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):101-6. PMID: 12182979.
      View in: PubMed
    51. Gdor Y, Timme TL, Miles BJ, Kadmon D, Thompson TC. Gene therapy for prostate cancer. Expert Rev Anticancer Ther. 2002 Jun; 2(3):309-21. PMID: 12113054.
      View in: PubMed
    52. Shalev M, Mistry S, Kernen K, Miles BJ. Squamous cell carcinoma in a female urethral diverticulum. Urology. 2002 May; 59(5):773. PMID: 11992925.
      View in: PubMed
    53. Teh BS, Aguilar-Cordova E, Vlachaki MT, Aguilar L, Mai WY, Caillouet J, Davis M, Miles B, Kadmon D, Ayala G, Lu HH, Chiu JK, Carpenter LS, Woo SY, Grant WH, Wheeler T, Thompson TC, Butler EB. Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist. 2002; 7(5):458-66. PMID: 12401909.
      View in: PubMed
    MILES's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description